» Articles » PMID: 22730322

Fas-associated Factor 1 is a Scaffold Protein That Promotes β-transducin Repeat-containing Protein (β-TrCP)-mediated β-catenin Ubiquitination and Degradation

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2012 Jun 26
PMID 22730322
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

FAS-associated factor 1 (FAF1) antagonizes Wnt signaling by stimulating β-catenin degradation. However, the molecular mechanism underlying this effect is unknown. Here, we demonstrate that the E3 ubiquitin ligase β-transducin repeat-containing protein (β-TrCP) is required for FAF1 to suppress Wnt signaling and that FAF1 specifically associates with the SCF (Skp1-Cul1-F-box protein)-β-TrCP complex. Depletion of β-TrCP reduced FAF1-mediated β-catenin polyubiquitination and impaired FAF1 in antagonizing Wnt/β-catenin signaling. FAF1 was shown to act as a scaffold for β-catenin and β-TrCP and thereby to potentiate β-TrCP-mediated β-catenin ubiquitination and degradation. Data mining revealed that FAF1 expression is statistically down-regulated in human breast carcinoma compared with normal breast tissue. Consistent with this, FAF1 expression is higher in epithelial-like MCF7 than mesenchymal-like MDA-MB-231 human breast cancer cells. Depletion of FAF1 in MCF7 cells resulted in increased β-catenin accumulation and signaling. Importantly, FAF1 knockdown promoted a decrease in epithelial E-cadherin and an increase in mesenchymal vimentin expression, indicative for an epithelial to mesenchymal transition. Moreover, ectopic FAF1 expression reduces breast cancer cell migration in vitro and invasion/metastasis in vivo. Thus, our studies strengthen a tumor-suppressive function for FAF1.

Citing Articles

SKP1-CUL1-F-box: Key molecular targets affecting disease progression.

Zeng X, Cao J, Xu J, Zhou Z, Long C, Zhou Y FASEB J. 2025; 39(2):e70326.

PMID: 39812503 PMC: 11734646. DOI: 10.1096/fj.202402816RR.


Exploring the role of ubiquitin regulatory X domain family proteins in cancers: bioinformatics insights, mechanisms, and implications for therapy.

Yang E, Fan X, Ye H, Sun X, Ji Q, Ding Q J Transl Med. 2024; 22(1):157.

PMID: 38365777 PMC: 10870615. DOI: 10.1186/s12967-024-04890-9.


Exosomal circRHCG promotes breast cancer metastasis via facilitating M2 polarization through TFEB ubiquitination and degradation.

Shen H, Xu J, Zhang W, Chen Q, Zhu Z, Mao Y NPJ Precis Oncol. 2024; 8(1):22.

PMID: 38287113 PMC: 10825185. DOI: 10.1038/s41698-024-00507-y.


High Expression of Fas-Associated Factor 1 Indicates a Poor Prognosis in Non-Small-Cell Lung Cancer.

Hu D, Yamada H, Yoshimura K, Ohta T, Tsuchiya K, Inoue Y Curr Oncol. 2023; 30(11):9484-9500.

PMID: 37999107 PMC: 10670600. DOI: 10.3390/curroncol30110687.


Beta-Transducin Repeats-Containing Proteins as an Anticancer Target.

Kim D, Yi Y, Seong Y Cancers (Basel). 2023; 15(17).

PMID: 37686524 PMC: 10487276. DOI: 10.3390/cancers15174248.


References
1.
MacDonald B, Tamai K, He X . Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009; 17(1):9-26. PMC: 2861485. DOI: 10.1016/j.devcel.2009.06.016. View

2.
Zhou F, Huang H, Zhang L . Bisindoylmaleimide I enhances osteogenic differentiation. Protein Cell. 2012; 3(4):311-20. PMC: 4875475. DOI: 10.1007/s13238-012-2027-4. View

3.
Gilles C, Polette M, Mestdagt M, Nawrocki-Raby B, Ruggeri P, Birembaut P . Transactivation of vimentin by beta-catenin in human breast cancer cells. Cancer Res. 2003; 63(10):2658-64. View

4.
Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, Zhao H . Stromal gene expression predicts clinical outcome in breast cancer. Nat Med. 2008; 14(5):518-27. DOI: 10.1038/nm1764. View

5.
Kemler R, Hierholzer A, Kanzler B, Kuppig S, Hansen K, Taketo M . Stabilization of beta-catenin in the mouse zygote leads to premature epithelial-mesenchymal transition in the epiblast. Development. 2004; 131(23):5817-24. DOI: 10.1242/dev.01458. View